BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29593542)

  • 21. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro.
    Johnson JL; Gonzalez de Mejia E
    Food Chem Toxicol; 2013 Oct; 60():83-91. PubMed ID: 23871783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression.
    Rezai-Zadeh K; Ehrhart J; Bai Y; Sanberg PR; Bickford P; Tan J; Shytle RD
    J Neuroinflammation; 2008 Sep; 5():41. PubMed ID: 18817573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds.
    Kim DI; Lee TK; Lim IS; Kim H; Lee YC; Kim CH
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):213-24. PubMed ID: 15922007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.
    Chen CC; Chow MP; Huang WC; Lin YC; Chang YJ
    Mol Pharmacol; 2004 Sep; 66(3):683-93. PubMed ID: 15322261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells.
    Coombs MRP; Harrison ME; Hoskin DW
    Cancer Lett; 2016 Oct; 380(2):424-433. PubMed ID: 27378243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteolin and Apigenin Attenuate LPS-Induced Astrocyte Activation and Cytokine Production by Targeting MAPK, STAT3, and NF-κB Signaling Pathways.
    Che DN; Cho BO; Kim JS; Shin JY; Kang HJ; Jang SI
    Inflammation; 2020 Oct; 43(5):1716-1728. PubMed ID: 32462548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of six flavonoid compounds from Ixeris sonchifolia on stimulus-induced superoxide generation and tyrosyl phosphorylation in human neutrophils.
    Lu J; Feng X; Sun Q; Lu H; Manabe M; Sugahara K; Ma D; Sagara Y; Kodama H
    Clin Chim Acta; 2002 Feb; 316(1-2):95-9. PubMed ID: 11750278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyphenols from plants used in traditional Indonesian medicine (Jamu): uptake and antioxidative effects in rat H4IIE hepatoma cells.
    Steffan B; Wätjen W; Michels G; Niering P; Wray V; Ebel R; Edrada R; Kahl R; Proksch P
    J Pharm Pharmacol; 2005 Feb; 57(2):233-40. PubMed ID: 15720788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation.
    Kim EK; Kwon KB; Song MY; Han MJ; Lee JH; Lee YR; Lee JH; Ryu DG; Park BH; Park JW
    Pancreas; 2007 Nov; 35(4):e1-9. PubMed ID: 18090225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
    Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
    Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.
    Hougee S; Sanders A; Faber J; Graus YM; van den Berg WB; Garssen J; Smit HF; Hoijer MA
    Biochem Pharmacol; 2005 Jan; 69(2):241-8. PubMed ID: 15627476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells.
    Chen D; Chen MS; Cui QC; Yang H; Dou QP
    Front Biosci; 2007 Jan; 12():1935-45. PubMed ID: 17127432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlating In Vitro Target-Oriented Screening and Docking: Inhibition of Matrix Metalloproteinases Activities by Flavonoids.
    Crascì L; Basile L; Panico A; Puglia C; Bonina FP; Basile PM; Rizza L; Guccione S
    Planta Med; 2017 Jul; 83(11):901-911. PubMed ID: 28288492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3',4'-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity.
    Schlupper D; Giesa S; Gebhardt R
    Planta Med; 2006 Jun; 72(7):596-603. PubMed ID: 16732514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.
    Huang YT; Lee LT; Lee PP; Lin YS; Lee MT
    Anticancer Res; 2005; 25(3B):2017-25. PubMed ID: 16158939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells.
    Chen YH; Wu JX; Yang SF; Yang CK; Chen TH; Hsiao YH
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.